|
|
Volumn 68, Issue 6, 2009, Pages 451-458
|
|
Fibromyalgia - The new guideline;Fibromyalgiesyndrom - die neue Leitlinie
|
|
Author keywords
Etiology; Fibromyalgia; Guideline; Multi modal therapy; Training therapy
|
|
Indexed keywords
ALPRAZOLAM;
AMITRIPTYLINE;
ANTIRHEUMATIC AGENT;
BROMAZEPAM;
CORTICOSTEROID;
DIPYRONE;
DULOXETINE;
FLUOXETINE;
GROWTH HORMONE;
HYPNOTIC AGENT;
KETAMINE;
LIDOCAINE;
MILNACIPRAN;
MOCLOBEMIDE;
MUSCLE RELAXANT AGENT;
OXYBATE SODIUM;
PARACETAMOL;
PAROXETINE;
PRASTERONE;
PREGABALIN;
RITANSERIN;
THYROID HORMONE;
TRAMADOL;
TROPISETRON;
ALTERNATIVE MEDICINE;
CLINICAL FEATURE;
CLINICAL TRIAL;
COGNITIVE THERAPY;
CONSENSUS DEVELOPMENT;
COURSE EVALUATION;
DISEASE CLASSIFICATION;
DRUG EFFICACY;
ENDURANCE;
EVIDENCE BASED MEDICINE;
EXPERIMENTAL MODEL;
FIBROMYALGIA;
HEALTH CARE PERSONNEL;
HUMAN;
JOB PERFORMANCE;
LONG TERM CARE;
MEDICAL SPECIALIST;
MUSCLE TRAINING;
PATHOGENESIS;
PATIENT EDUCATION;
PRACTICE GUIDELINE;
PSYCHOLOGICAL ASPECT;
REVIEW;
SOCIAL ASPECT;
THERAPY EFFECT;
FIBROMYALGIA;
GERMANY;
PHYSICIAN'S PRACTICE PATTERNS;
PRACTICE GUIDELINES AS TOPIC;
RHEUMATOLOGY;
|
|
EID: 68849107309
PISSN: 03401855
EISSN: None
Source Type: Journal
DOI: 10.1007/s00393-009-0454-2 Document Type: Review |
|
Times cited : (7)
|
|
References (24)
|
